Patterns of etanercept use in juvenile idiopathic arthritis in the Childhood Arthritis and Rheumatology Research Alliance Registry
Timothy Beukelman(University of Alabama at Birmingham), Alexis Boneparth(University of California, San Francisco), J. Bohnsack, L. Barillas-Arias(University of California, San Francisco), Stephen J. Balevic(Duke University), Risa Alperin(University of California, San Francisco), Heather Benham(University of California, San Francisco), Michael Blakley(Indiana University Health), David H. Collier(Amgen (United States)), E. Beltz(Hospital for Special Surgery), William Bernal(King's College - North Carolina), Aimee Lougee(Duke University), M. Becker(Amgen (United States)), Fatima Barbar‐Smiley(University of California, San Francisco), K. Abulaban, Scott Stryker(Amgen (United States)), Susanne M. Benseler(Royal College of Surgeons in Ireland), H. Bell-Brunson(University of California, San Francisco), Stacy P. Ardoin(The Ohio State University), I. Balboni(Amgen (United States)), Shoghik Akoghlanian(Nationwide Children's Hospital), S. Armendariz(University of California, San Francisco), Dax G. Rumsey(University of Alberta), Matthew L. Basiaga(Mayo Clinic in Florida), Marinka Twilt(University of Calgary), J. Aiello(University of California, San Francisco), M. Alpizar(Cornell University), J. Boland, Emma H. Baker(St George's, University of London), Kevin Baszis(Washington University in St. Louis), Yukiko Kimura(Hackensack University Medical Center), G. Amarilyo(University of Calgary), Jennifer Schenfeld(Amgen (United States)), T. Bigley(University of California, San Francisco), Nayimisha Balmuri(Hospital for Special Surgery), E. Allenspach(University of California, San Francisco), N. Abel(Hospital for Special Surgery), Andrew Adams(University of Minnesota), William G Ambler(University of California, San Francisco), Roland Matsouaka(Duke University), R. Agbayani, L. Ballenger(University of California, San Francisco), C. Black(University of California, San Francisco), Matthew Adams(University of California, San Francisco), C. Alejandro(University of California, San Francisco), E. Anderson(Amgen (United States)), S. Ballinger(Hospital for Special Surgery), B. Binstadt(Amgen (United States))
Cited by 5
Related Papers
A clinical approach to diagnosis of autoimmune encephalitis
|The Lancet Neurology|2016|4.4k
Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study
|The Lancet Neurology|2013|3.1k
2012 Update of the 2008 American College of Rheumatology recommendations for the use of disease‐modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis
|Arthritis Care & Research|2012|1.8k
HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin
|Nature Genetics|2009|1.1k
Rational Development of LEA29Y (belatacept), a High-Affinity Variant of CTLA4-Ig with Potent Immunosuppressive Properties
|American Journal of Transplantation|2005|714